Trials / Conditions / Acute Lymphoblastic Leukemia Refractory
Acute Lymphoblastic Leukemia Refractory
4 registered clinical trials studyying Acute Lymphoblastic Leukemia Refractory — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia NCT07371403 | King Hussein Cancer Center | N/A |
| Recruiting | Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia NCT04881240 | St. Jude Children's Research Hospital | Phase 1 |
| Recruiting | Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lympho NCT05705570 | Nelson Hamerschlak | Phase 1 |
| Active Not Recruiting | Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute NCT03573700 | St. Jude Children's Research Hospital | Phase 1 / Phase 2 |